Futura Medical (LON:FUM) Stock Price Up 13% – What’s Next?

Futura Medical plc (LON:FUM)’s share price was up 13% during mid-day trading on Wednesday . The stock traded as high as GBX 0.40 and last traded at GBX 0.39. Approximately 3,204,701 shares were traded during mid-day trading, a decline of 68% from the average session volume of 10,090,577 shares. The stock had previously closed at GBX 0.34.

Futura Medical Stock Performance

The firm has a fifty day moving average of GBX 0.56 and a 200 day moving average of GBX 0.97. The firm has a market capitalization of £2.27 million, a PE ratio of -0.14 and a beta of 0.02.

Futura Medical (LON:FUM) last announced its earnings results on Wednesday, April 29th. The company reported GBX (2.78) earnings per share for the quarter. The firm had revenue of GBX 170 million during the quarter. Futura Medical had a negative net margin of 534.62% and a negative return on equity of 310.00%. Research analysts forecast that Futura Medical plc will post 2.8486672 earnings per share for the current fiscal year.

Futura Medical Company Profile

Futura Medical plc (AIM: FUM) is the developer of innovative sexual health products, including lead product Eroxon® and products WSD4000 and Eroxon® Intense. Our core strength lies in our research, development and commercialisation of topically delivered gel formulations in sexual health products.

Sexual health issues are prevalent in both men and women. ED impacts 1 in 5 men globally across all adult age brackets, with approximately half of all men over 40 experiencing ED and 25% of all new diagnoses being in men under 40.